Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 7/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CTSL | P07711 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13390866 | 0.84 | ALDH1A1 (0.61) | ALDH1A1TSHRHSD17B10EPHX2P2RX7 | |
| SCHEMBL13609289 | 0.78 | KMT2A (0.60) | ALDH1A1TSHRHSD17B10EPHX2SMN1; SMN2 | |
| SCHEMBL25881311 | 0.78 | EPHX2 (0.55) | ALDH1A1TSHRHSD17B10EPHX2P2RX7 | |
| SCHEMBL11076664 | 0.76 | ALDH1A1 (0.70) | ALDH1A1TSHRHSD17B10EPHX2P2RX7 | |
| SCHEMBL14503281 | 0.75 | HSD17B10 (0.67) | ALDH1A1TSHRHSD17B10EPHX2P2RX7 | |
| SCHEMBL660424 | 0.74 | ALDH1A1 (0.68) | ALDH1A1TSHRHSD17B10EPHX2P2RX7 | |
| SCHEMBL15858506 | 0.74 | ALDH1A1 (0.53) | ALDH1A1TSHRHSD17B10EPHX2P2RX7 | |
| SCHEMBL23195092 | 0.73 | ALDH1A1 (0.66) | ALDH1A1TSHRHSD17B10EPHX2P2RX7 | |
| SCHEMBL2290939 | 0.72 | ALDH1A1 (1.00) | ALDH1A1TSHRHSD17B10EPHX2P2RX7 | |
| SCHEMBL14644919 | 0.72 | ALDH1A1 (0.70) | ALDH1A1TSHRHSD17B10EPHX2P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0832076-A1 | NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-04-01 | — | — | EP | claimed |
| WO-1996038426-A1 | NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-12-05 | — | — | WO | claimed |
| EP-0730590-A1 | NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-09-11 | — | — | EP | claimed |
| EP-0832076-A1 | NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996038426-A1 | NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-12-05 | — | — | WO | disclosed |
| EP-0730590-A1 | NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-09-11 | — | — | EP | disclosed |